Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Array BioPharma | Contract Pharma
Breaking News, Promotions & Moves

Array BioPharma

Array BioPharma, Inc. has appointed April H. Teitelbaum, M.D., MS, FACP, to the newly created position of vice president of clinical development, oncology. Dr. Teitelbaum will oversee the medical strategy and clinical development of the company’s oncology drug pipeline and will report to the company’s chief executive officer, Robert E. Conway.

“April’s solid track record and experience in developing new cancer drugs will be invaluable to Array as we advance our extensive drug pipeline,” said Mr. Conway. “April’s expertise in running complex clinical trials will be a competitive advantage for Array as we are on track for having five drugs in clinical development by the end of 2006.”

For the last 16 years, Dr. Teitelbaum has held positions of increasing responsibility for clinical and strategic development of oncology therapeutics at several pharmaceutical and biotechnology companies including Amgen, Sequus Pharmaceuticals, Ligand, Johnson and Johnson, and Kyowa Pharmaceuticals. She has been involved in clinical development, including registration strategies and expansion of label for multiple oncology therapeutics, including Neupogen, Doxil, and Yondelis. Dr. Teitelbaum also headed her own consulting company and has served as a consultant to several companies for development of novel oncology therapeutics. Prior to that Dr. Teitelbaum was engaged in private practice, specializing in Hematology and Medical Oncology.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters